Skip to main content

Latest SEC Filings — Page 24

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Director/Chair Xiaodong Wang Files to Sell $47M in BeOne Medicines ADSs
Form 144ONC · Form 144 · 5d ago
Aterian Receives Nasdaq Delisting Notice for Bid Price Deficiency; CEO Takes Interim CFO Role
ProForm 8-KATER · Form 8-K · 5d ago
Mission Produce Swings to Q3 Loss as Calavo Integration Costs Bite
Form 10-QAVO · Form 10-Q · 5d ago
Smithfield Cuts 3Q Outlook: Fresh Pork Loss of $70M–$90M, Total Adjusted Operating Income $115M–$175M
Form 8-KSFD · Form 8-K · 5d ago
MMEX Raises $3.8M via Subsidiary Stake Sale, Settles Sabby Litigation, and Secures TCEQ Permit
ProForm 10-QMMEX · Form 10-Q · 5d ago
BBOT Reports 75% ORR for BBO-8520 + Pembrolizumab in G12C Inhibitor-Experienced NSCLC
Form 8-KBBOT · Form 8-K · 5d ago
BNED Q1 Loss Narrows but Material Weaknesses Persist; Debt Jumps $52.5M
ProForm 10-QBNED · Form 10-Q · 5d ago
Mission Produce Lifts Calavo Synergy Target Above $30M, Reaffirms H2 EBITDA Guidance
Form 8-KAVO · Form 8-K · 5d ago
AII Furnishes Investor Deck Ahead of KBW Conference: $3B Reinsurance Tower Finalized, Voluntary Premiums Up 150%
Form 8-KAII · Form 8-K · 5d ago
Blue Owl Capital Completes $398M CLO Securitization Backed by Middle Market Loans
Form 8-KOBDC · Form 8-K · 5d ago
ATG Capital Withdraws Five Board Nominees, Files New Proxy Slate
Form SCHEDULE 13D/AEMPD · Form SCHEDULE 13D/A · 5d ago
Cascade Investment Adds $164.7M to Republic Services Stake
Form 4RSG · Form 4 · 5d ago
Kenon Q2 Profit Jumps to $54M as OPC Revenue Nearly Doubles
Form 6-KKEN · Form 6-K · 5d ago
InterCure Regains Nasdaq Compliance, Averting Delisting Threat
ProForm 6-KINCR · Form 6-K · 5d ago
InnovAge Posts Q4 Beat, Swings to Profit, and Issues FY27 Guidance
Form 8-KINNV · Form 8-K · 5d ago
BNED Reaffirms FY27 Outlook as First Day Complete Enrollment Climbs to 1.43M Students
Form 8-KBNED · Form 8-K · 5d ago
Braveheart Bio Reports Q2 2026 Results, Initiates Phase 3 LIONHEART-HCM Trial, Extends Cash Runway to 2029
Form 8-KBRVE · Form 8-K · 5d ago
ServiceTitan Q2 Revenue Up 21%, Raises Full-Year Non-GAAP Operating Income Outlook
Form 8-KTTAN · Form 8-K · 5d ago
BJ's Wholesale Club Announces $240M Credit Card Interchange Fee Settlement
ProForm 8-KBJ · Form 8-K · 5d ago
Completes $50M Asset Sale to Eli Lilly; Reports July Operating Loss of $11.17M in Bankruptcy
ProForm 8-KSGMOQ · Form 8-K · 5d ago
Shareholders to Vote on 10x Increase in Authorized Capital and New M&A
ProForm 6-KAIIO · Form 6-K · 5d ago
XCF Global Restructures Toxic Debt: Removes 5M Penalty Shares, Converts $840K Note at $0.24
ProForm 8-KSAFX · Form 8-K · 5d ago
Medalist Diversified Enters $4M Joint Venture, Reinstates Caliber Acquisition, and Closes Brookfield Sale
Form 8-KMDRR · Form 8-K · 5d ago
Cytosorbents Finalizes 1-for-20 Reverse Split Effective September 8
Form 8-KCTSO · Form 8-K · 5d ago
FDA Accepts Intellia's BLA for Lonvo-z with Priority Review; PDUFA Date Set for March 10, 2027
ProForm 8-KNTLA · Form 8-K · 5d ago
ArcBest Reports Strong August Freight Trends, Guides Asset-Light Operating Income to $8M-$10M
Form 8-KARCB · Form 8-K · 5d ago
CEO Mark Lappe Buys $2.65M of INBX Stock on Day of Positive Phase 2 Data
Form 4INBX · Form 4 · 5d ago
Enbridge CEO Greg Ebel to Retire; Michele Harradence Named Successor Effective Jan 1, 2027
Form 8-KENB · Form 8-K · 5d ago
KE Holdings H1 2026 Net Income Nearly Doubles to RMB3.9B Despite 12% Revenue Decline
Form 6-KBEKE · Form 6-K · 5d ago
LiqTech CFO/COO David Kowalczyk to Resign Effective November 30, 2026
Form 8-KLIQT · Form 8-K · 5d ago